SITC Cancer Immunotherapy CONNECT

SITC 2022 Logo.png

Submit your Cutting-edge Research

SITC 2022 is now accepting submissions for Regular abstracts, Young Investigator Award abstracts and/or applications for Late-breaking abstracts. The abstract deadline is 5 p.m. PDT on July 28, 2022.


SITC 2022 Logo.png

Register Now

Join us at our 37th Annual Meeting & Pre-Conference Programs on Nov. 8–12, 2022 at the Boston Convention & Exhibition Center in Boston, MA. Virtual participation also available.


Rosenberg Scholars Award

Nominate an Emerging Leader in IO

SITC is seeking the best and brightest for the 2022 Steven A. Rosenberg Scholars Award, one of the society's most prestigious opportunities for early career scientists.



Comprehensive Learning Center:
Year 8

Immunotherapy - A Revolutionary Approach for Difficult-to-Treat Cancers. CME activities developed through a partnership between Medscape and SITC.

Learn More

SITC CIG App Homescreen Cropped

Download the new SITC Clinical Practice Guidelines (CPG) Mobile App!
The first and only immunotherapy-specific clinical practice guidelines app featuring guideline content and expert panel recommendations in an easy-to-navigate format. The app includes interactive tools, bookmarks, and advanced search capabilities.
Available for FREE for iOS and Android.

Learn More

New SITC Clinical Practice Guidelines Published

  • Acute Leukemia
  • Breast Cancer
  • Hepatocellular Carcinoma
  • Immune Checkpoint Inhibitor-related Adverse Events
  • New! Lung Cancer and Mesothelioma
  • Urothelial Cancer
Free companion educational webinars available.
Target for Cancer IO.png

Targets for Cancer IO: A Deep Dive Series

This highly anticipated series addresses key cancer IO questions in depth, and with top faculty leading the discussion. Register soon! Special offer available.

LEARN MORE and register

JITC Anniversary

Celebrate a Decade of Publishing
with SITC’s Official Journal

  • Hear from editors about the state of the field
  • Explore the journal’s major milestones
  • Read top content



For patients

Explore comprehensive resources and educational opportunities for cancer patients and those who advocate for them.



For Clinicians

Track the latest advancements and educational opportunities in cancer immunotherapy and immunology.



For Researchers

Advance science, submit your manuscript and monitor the global progress of cancer immunotherapy research.


Latest Discussions

  • With support of New PI Cell & Developmental Biology community, we are organizing a panel discussion event. Six New PIs from US and Europe will share their experiences in job market, lab set up and take questions from audience. Target audience: postdocs ...

  • Animal Models for Cancer Interception and Precision Prevention Virtual Workshop Sponsored by the Division of Cancer Prevention, and the Division of Cancer Biology, NCI Date : October 13-14, 2022 Workshop Objectives: The main ...

  • ------------------------------ Altaf Mohammed PhD NCI Bethesda MD ------------------------------


Follow the SITC Twitter Feed.

Connect with colleagues at these Upcoming Events.

Ignite the SITC Sparkathon

Donate today to support early career scientists who are emerging leaders
seeking toadvance research in the cancer immunotherapy field.

Learn More

The Journal & The Blog

Journal for ImmunoTherapy of Cancer

An open access, peer-reviewed journal, the Journal for ImmunoTherapy of Cancer (JITC) is the global voice of the society, producing original research articles, literature reviews and more on tumor immunology and cancer immunotherapy.

Learn More

  • Hello JITC Readers, June is always a special month for the journal and our field as we celebrate...
  • Hello JITC Readers, This month’s JITC digest marks the beginning of the journal’s 10th anniversary...
  • Hello JITC Readers, In the northern hemisphere, spring is in the air and conference season is just...


Making Cure a Reality

It is the mission of the Society for Immunotherapy of Cancer (SITC) to improve cancer patient outcomes by advancing the science, development and application of cancer immunology and immunotherapy through our core values of interaction/integration, innovation, translation and leadership in the field. SITC aims to make cancer immunotherapy a standard of care and the word “cure” a reality for cancer patients everywhere.


Learn More